Intravenous thrombolysis (IVT) represents the only systemic reperfusion therapy able to
reverse neurological deficit in patients with acute ischemic stroke (AIS). Despite its …

Aim Our study aimed to explore the effectiveness and safety of intravenous t‐PA compared
with dual antiplatelet therapy (DAPT) and aspirin alone for minor stroke with National …

Determining acute ischemic stroke (AIS) etiology is fundamental to secondary stroke
prevention efforts but can be diagnostically challenging. We trained and validated an …

Background and Purpose: Although most strokes present with mild symptoms, these have
been poorly represented in clinical trials. The objective of this study is to describe …

Background and Purpose—The first of the 2 NINDS (National Institute of Neurological
Disorders and Stroke) Study trials did not show a significant increase in early neurological …

Pterostilbene (PTE), a natural stilbene found in blueberries and several varieties of grapes,
has several pharmacological activities, including anti-inflammatory and antioxidative …

Objective The purpose of this study was to update trends, investigate sociodemographic
disparities, and evaluate the impact on mortality of stroke neuroimaging across the United …

Alteplase is the only Food and Drug Administration-approved intravenous (IV) thrombolytic
medication for acute ischemic stroke. However, multiple recent studies comparing …

Background China is one of the countries with the highest burden of stroke. Implementing
multidimensional management guidelines will help clinicians practise evidence-based care …

Background: Whether bridging therapy (intravenous thrombolysis [IVT] followed by
mechanical thrombectomy) is superior to IVT alone in minor stroke with large vessel …